THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 144 filers reported holding THERAPEUTICSMD INC in Q4 2017. The put-call ratio across all filers is 2.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2018 | $4,000 | -42.9% | 1,000 | -9.1% | 0.00% | – |
| Q3 2018 | $7,000 | 0.0% | 1,100 | 0.0% | 0.00% | – |
| Q2 2018 | $7,000 | -30.0% | 1,100 | -31.2% | 0.00% | – |
| Q1 2018 | $10,000 | 0.0% | 1,600 | 0.0% | 0.00% | – |
| Q4 2017 | $10,000 | -64.3% | 1,600 | -69.9% | 0.00% | -100.0% |
| Q3 2017 | $28,000 | -17.6% | 5,322 | -17.1% | 0.00% | 0.0% |
| Q2 2017 | $34,000 | -27.7% | 6,422 | -1.5% | 0.00% | -50.0% |
| Q1 2017 | $47,000 | +20.5% | 6,522 | -3.0% | 0.00% | 0.0% |
| Q4 2016 | $39,000 | +680.0% | 6,722 | +831.0% | 0.00% | – |
| Q3 2016 | $5,000 | -28.6% | 722 | -12.2% | 0.00% | – |
| Q2 2016 | $7,000 | – | 822 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,460,225 | $24,914,000 | 4.95% |
| Newtyn Management, LLC | 1,800,000 | $12,960,000 | 1.95% |
| 1492 Capital Management LLC | 222,485 | $1,602,000 | 1.25% |
| SANDERS MORRIS HARRIS LLC | 967,200 | $6,964,000 | 1.18% |
| MORGENS WATERFALL VINTIADIS & CO INC | 180,000 | $1,296,000 | 1.15% |
| SPHERA FUNDS MANAGEMENT LTD. | 580,000 | $4,176,000 | 0.82% |
| Rock Springs Capital Management LP | 1,600,000 | $11,520,000 | 0.66% |
| STONERIDGE INVESTMENT PARTNERS LLC | 467,425 | $3,365,000 | 0.45% |
| Capital Impact Advisors, LLC | 157,411 | $1,133,000 | 0.45% |
| GILDER GAGNON HOWE & CO LLC | 3,059,690 | $22,030,000 | 0.37% |